ArticleBritish journal of haematology2022

Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID-19.

Tali Shafat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.